When I left the apartment building today, a maintenance man working for the landlord said "Stay 6 feet away **^*%*@ucker, social distancing . . . " With that language, we almost got a lot closer . . .

Moderators: wdolson, MOD_War-in-the-Pacific-Admirals-Edition

ORIGINAL: obvert
ORIGINAL: Chickenboy
Back to the topic at hand:
https://ourworldindata.org/covid-mortality-risk
ETA: The article also does a very nice job in distinguishing between the "Case Fatality Rate" and the "Infection Fatality Rate". Very often (and the author cites a particularly craptastic piece of journalism by the New York Times) the media misstates what they're looking for and misapplies the terms.
A good read and although I wasn't clear on the precise use of terms before, I get them now, and realise most reports I've read use the two ideas whether they use the terms or not.
I just read the referenced NY Times article, which I'read a the time as well. I found the graph showing fatality rates useful as it distinguished between many known diseases in their transmission capability vs fatality rate. As far as I could tell the article steers clear of BOTH terms, probably so as not to confuse the general reader while still getting across that main piece of knowledge at the time, which is that this Coronavirus is more lethal than the flu and they show a range in the graph below.
At the bottom of the graph the term Case Fatality Rate is used with a disclaimer that these numbers "vary" and that the Covid numbers were preliminary, which seemed exactly what the writer of the outworldindata piece was trying to assert.
So I can't figure out what is wrong with trying to provide some early estimates and comparisons to more known diseases while cautioning that it was still too early to tell for sure. Seemed pretty responsible to me.
There is a lot of incomplete, irresponsible journalism out there but I don't find this NY Times article to fall in that category.

ORIGINAL: Canoerebel
He was referring to cases in general, not mortality.
ORIGINAL: Canoerebel
Looking at this again, the irrationality of the numbers we're getting from the media and the experts seems apparent.
Most of them are estimating infection rates of 50% to 70% in the US. That means about 170,000,000 to 238,000,000 should be infected. Using the "standard" (nearly universally accepted) mortality rate of 1% yields and expected death toll of 1,750,000 to 2,380,000.
Since those totals are 10x or more what the experts are now floating, there's something wrong. Either the 50% to 70% is way off or the mortality rate is way off. If it's the latter, and if Dr. Fauci is right at 100k to 200k mortality, that means the mortality rate is something like 0.1% or less, which is the same or less than seasonal flu.
So if it isn't the mortality rate that's off, its the infection rate. Instead of 50% or 70% of the nation being infected it would be more like 5%! (5% of 340,000,000 x 1% yields 170k, a figure within Dr. Fauci's range).
Or it could be that both numbers are off considerably.
Not matter what, the numbers don't add up. They never add up. The media and the experts are so focused on working with numbers that they torture them and don't realize the outcomes contradict each other. Either we're going to have a lot less infected than they're predicting or the mortality rate is going to be much less than 1%....or both. My bet is the latter.
ORIGINAL: Canoerebel
Last year, I re-read Stephen King's The Stand. It's a terrific novel about a bio-weapon escape that kills most of humanity. The few survivors begin having dreams.
Last week, there were reports in the news of people having dreams! Zoiks, thinks I!
Anyhow, The Stand is a great read but might be too rattling right now.
THere was also a miniseries starring Molly Ringwald and Gary Sinese. I don't know if it is any good, as I've never seen it. But it's apparently available on YouTube, here: https://www.youtube.com/watch?v=0e64sPHWnsY
I might watch it, but I definitely won't encourage my wife to.
ORIGINAL: Chickenboy
ORIGINAL: Lokasenna
It's doubtful that I'll have time tomorrow during work hours (and after that I'm going outside), but if we can agree on a source to use (Johns Hopkins?), I can put these into Excel for daily visualization.
This source, as well as these below, have been my daily stalwarts:
covidtracking.com/data/ (which has the state by state data in 'data as a spreadsheet') and
worldometers.info/coronavirus/#countries (for the global picture)
ORIGINAL: Canoerebel
If your dreams involve "Mother Abigail" sitting on the front porch of an old ramshackle house set in a Nebraska cornfield, you're one of the good guys. If, on the other hand, the subject is "The Walking Dude" aka Randall Flagg, go to church immediately with sincerity and purity of heart and stop dreaming about naked Buddy Hacketts.
P.S. I dream a lot. Usually nightmares that I'm still a lawyer (seriously). But my dreams are no more or less frequent.
ORIGINAL: Chickenboy
Back to the topic at hand:
https://ourworldindata.org/covid-mortality-risk
Really good discussion of issues impacting CFR. Many of these have been bandied about here, but this is a well-written and concise article. Highly recommended to check out the 'slider' on the lower right corner of the page that compares different regional / national CFRs over time.
ETA: The graph at the bottom right of the page with the slider is actually reflective of the "Infection Fatality Rate" rather than the Case Fatality Rate so misused in the media. I'm more interested in the IFR as it reflects what most people are interested in: "If I get this, what are the odds that it will make me sick enough to die?" The Case Fatality Rate includes nebulous factors such as willingness to go to hospital, quality of medical care locally, what one's definition of a 'case' is and so forth.
I think a salient point the authors made was that as the number of positive tests increase exponentially, if deaths only increase linearly then that drops the CFR. In other words, more testing = more 'ground truth' for what this virus really means for a given population. Since the bodies are harder to hide (except in China apparently), if you want to drop the CFR, find more positive people in your burgeoning testing program. Those that only preferentially test the sickest hospital admissions cases will artificially elevate their CFR.
ETA: The article also does a very nice job in distinguishing between the "Case Fatality Rate" and the "Infection Fatality Rate". Very often (and the author cites a particularly craptastic piece of journalism by the New York Times) the media misstates what they're looking for and misapplies the terms.
ORIGINAL: Canoerebel
You're right, John: Today, the Guadalcanal campaign is memorable for two reasons. First, it was the closest the U.S. came to losing the war in the Pacific, but second, its victory put America on the offensive against Japan for the rest of the war. It was, as Winston Churchill said, “not even the beginning of the end, but it is, perhaps, the end of the beginning.” https://www.saturdayeveningpost.com/201 ... beginning/
I've always thought the quote specifically applied to Guadalcanal, though the source/quote above doesn't make that absolutely clear.

Chicken Littles! [:D]ORIGINAL: Chickenboy
And, because some of them were catty, nobody listened to the dogged optimism of the Veterinarians.
warspite1ORIGINAL: Canoerebel
You're right, John: Today, the Guadalcanal campaign is memorable for two reasons. First, it was the closest the U.S. came to losing the war in the Pacific, but second, its victory put America on the offensive against Japan for the rest of the war. It was, as Winston Churchill said, “not even the beginning of the end, but it is, perhaps, the end of the beginning.” https://www.saturdayeveningpost.com/201 ... beginning/
I've always thought the quote specifically applied to Guadalcanal, though the source/quote above doesn't make that absolutely clear.
ORIGINAL: geofflambert
...
In the end, the Proctologists won out, leaving the strategy to the assholes in Washington.
ORIGINAL: alanschu
Wife is feeling ill (cough, aches, runny nose) and she called health service early in the morning. They feel that it's probably not Covid, but have asked us to isolate for 10 days as a precaution.
Primarily only affects her (she still had to go to work, now is not), but will mean we don't do any provision runs (we should be okay though).
Here is the list of symptoms from that Johns Hopkins page.ORIGINAL: obvert
ORIGINAL: alanschu
Wife is feeling ill (cough, aches, runny nose) and she called health service early in the morning. They feel that it's probably not Covid, but have asked us to isolate for 10 days as a precaution.
Primarily only affects her (she still had to go to work, now is not), but will mean we don't do any provision runs (we should be okay though).
Runny nose is rarely a symptom, but who knows these days for the mild cases. Stay well and hope she feels better soon.
https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540747/all/Coronavirus_COVID_19__SARS_CoV_2_#1Symptoms
Fever (44%–98%)
Range may be lower at initial hospital presentation or in the outpatient setting
Cough (46–82%, usually dry)
Shortness of breath at onset (31%)
Myalgia or fatigue (11–44%)
Less common symptoms:
Pharyngitis
Headache
Productive cough
GI symptoms
Have been described as a presenting symptom, and potentially heralding more severe illness.
Hemoptysis

ORIGINAL: obvert
Runny nose is rarely a symptom, but who knows these days for the mild cases. Stay well and hope she feels better soon.
Aberdeen, S.D., got the call from headquarters on Tuesday, Jan. 21. He gathered about 20 managers and supervisors into a conference room, where they sat, unworried, less than 6 feet apart. Rehder told them that a new virus was spreading rapidly in China and that 3M was expecting demand for protective gear to jump.
The Aberdeen plant had already ramped up production of respirator masks in response to demand from first responders battling wildfires in Australia and contending with a volcano in the Philippines. Now, Rehder told his charges, Aberdeen would shift to “surge capacity.” Idle machinery installed for precisely this purpose would be activated, and many of the plant’s 650 employees would immediately start working overtime. “We knew it wouldn’t be a two-week blip, it would be longer,” Rehder says. “But I had no idea.”
relates to How 3M Plans to Make More Than a Billion Masks By End of Year
Featured in Bloomberg Businessweek, March 30, 2020. Subscribe now.
Photo illustration: 731; Photographer: Jamie Chung for Bloomberg Businessweek
This is 3M’s moment, one for which the staid, 118-year-old Minnesota manufacturing giant—the maker of Post-its, Scotch tape, touchscreen displays, and scores of other products—has been preparing for almost two decades. Coming out of the SARS epidemic of 2002-03, the company realized it wasn’t fully equipped to handle unexpected explosions of demand in the event of a crisis, or what it calls an “X factor.” It decided to build surge capacity into its respirator factories around the world.
Over the years, with X factors such as the Ebola panic and the H1N1 flu virus generating flash floods of demand, the company kept refining its emergency response. When the world started clamoring for respirator masks to help confront coronavirus, 3M was ready.
People everywhere are scrambling for ventilators, Covid-19 test kits, bleach, and toilet paper. But almost no item is as scarce—and as vital to addressing this medical emergency—as the N95 respirator masks made by 3M, Honeywell, Medicom, and a smattering of other companies. Without respirators, doctors, nurses, and other medical personnel are at increased risk of contracting the affliction they’re treating.
China, where this coronavirus originated, also happens to produce half the world’s respirators. As the outbreak spread, the Chinese government halted mask exports and demanded that all in-country manufacturers, including 3M, crank up production. Shortages swiftly developed as Covid-19 cases appeared in Asia, Europe, and the U.S., forcing health-care workers to reuse old respirators and cobble together ersatz masks from materials bought at craft stores. In America, states are bidding against one another for masks priced as much as 10 times the usual cost of 60¢ to 80¢ apiece.
3M can’t save the day on its own, but it’s promising a remarkably large contribution. The company has in two months doubled global production of N95 masks to about 100 million a month, and it’s planning to invest in new equipment to push annual mask production to 2 billion within 12 months. On March 22, Chief Executive Officer Mike Roman said in a news release that 3M had sent 500,000 respirators to hard-hit Seattle and New York City, and that it was ramping up production of hand sanitizers and disinfectants as well. Two days later, Roman said 3M would work with Ford Motor Co. to produce powered air purifying respirators, waist-mounted devices that blow air into helmets that shield wearers. Honeywell is also increasing N95 production, saying it will hire at least 500 people to expand capacity at a facility in Rhode Island.